ALT Transplantation Direct Cover for October 2023

ALT Transplantation August 2023 Volume 107 Number 8. On the cover: Description of the basis of diagnosis of death in patients diagnosed by the donation after cessation of circulation in which in situ normothermic thoracic regional perfusion could return circulation to the brain. Bernat et al. Transplantation 2023;107:1650-1654.

ALT Visual Abstract for the article entitled Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study

ALT FIGURE 1. Recommended process for management for alcohol-associated liver disease in transplantation.

ALT Visual Abstract for the Review entitled Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot

ALT Transplantation Direct Cover for May 2023

ALT Transplantation April 2023 Volume 107 Number 4. On the cover: Outcomes of Liver Transplantation in Patients with Preexisting Coronary Artery Disease. Reznicek et al. Patient survival after liver transplantation based on the presence or absence of pretransplant coronary artery disease and NASH. Transplantation 2023;107:933-940.

ALT Visual Abstract for the article entitled Evaluating the Potential for ABO-incompatible Islet Transplantation: Expression of ABH Antigens on Human Pancreata, Isolated Islets, and Embryonic Stem Cell-derived Islets

ALT Visual Abstract for the article entitled Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study

ALT Transplantation March 2023 Volume 107 Number 3. On the cover: Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype. Tambur et al. The difference between an eplet and an epitope: (A) 4 eplets (yellow) are depicted on the background of an HLA class I molecule (α chain—green, β2 microglobulin—light blue, peptide—pink); (B) a rough depiction of the antibody footprint/epitope, assuming each eplet is a “core” for an epitope, is represented by a circle of a different color (purple, orange, blue, and yellow). This schematic representation clearly demonstrates that the footprint of the antibody may include additional eplets, beyond the “core” eplet. It further demonstrates that there is an overlap between the area of these epitopes such that‚ if 1 antibody binds to its target, other antibodies will be blocked from accessing their cognate epitope and therefore will likely not bind... Transplantation 2023;107:605-615.

ALT Visual Abstract for the article entitled Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients